Dr. Sulaiman Al-Habib Medical Services Group Co.
Head of Internal Audit Department
Senior Vice President of Medical Affairs
Chief Medical Officer
Founder & Non-Executive Chairman
Group CFO, Executive Director & CEO of the Group
Chief People Officer
Chief Operating Officer
Group General Counsel & Secretary of the Board
Senior VP of Physicians Affairs & Director
Chief of Business Development & Strategy and Executive Director
Board of Directors approves Final Dividend of SAR 0.25 per share for FY2025
Feb 28, 2026
Dr. Sulaiman Al-Habib Medical Services Group announces FY2025 Financial Results
Feb 28, 2026
Board of Directors Approves Final Dividend for 2025
Feb 20, 2026
Dr. Sulaiman Al-Habib Medical Services Group Reports Full Year 2025 Results
Feb 15, 2026
Annual General Meeting Notice 2026
Jan 15, 2026
Q3 2025 Financial Results: Revenue growth of 18% year-on-year
Nov 15, 2025
Related Party Transaction - Equipment Supply Agreement
Nov 2, 2025
Material Contract Signed for New Hospital Facility Development
Oct 5, 2025
Appointment of New Independent Board Member
Sep 10, 2025
Interim Dividend Distribution for First Half 2025
Aug 25, 2025
See Data Freshness Monitor for platform-wide data quality.
Moderate
8-factor live score
7/100
62/100
Caution: M-Score elevated
SouqData provides data for informational purposes only. This does not constitute financial advice, a personal recommendation, or an offer to buy or sell any security. Information may contain errors or be outdated. Always verify data independently and consult a licensed financial adviser before making investment decisions.
| Company | Market cap (USD) | Dividend yield | Governance | Shariah |
|---|---|---|---|---|
| Dr. Sulaiman Al-Habib Medical Services Group Co. (4013) | $6.3B | — | 42(D) | — |
| Mouwasat Medical Services Co. (4002 · TDWL) | $1.0B | — | 44(D) | — |
| Dallah Healthcare Co. (4004 · TDWL) | $972M | — | 24(F) | — |
| Astra Industrial Group (1212 · TDWL) | $868M | — | 27(F) | — |
| Jamjoom Pharmaceuticals Factory Co. (4015 · TDWL) | $748M | — | 45(D) | — |
| Dr. Soliman Abdul Kader Fakeeh Hospital Co. (4017 · TDWL) | $561M | — | 24(F) | — |
Auto-generated peer set — same GICS sector, comparable market-cap band. Governance score is the unified 8-factor model (independence, board size, CEO/chair separation, attendance, auditor, credentials, committees, pay transparency). Shariah uses AAOIFI Standard No. 21. View all 58 sector peers.
Get unlimited access to 180+ insight pages, AI copilot, deep research reports, watchlists, portfolio tracking, and the full 210-column screener across 11 MENA exchanges.
